Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03937804 · ClinicalTrials.gov registry record

New Approaches for Empowering Studies of Asthma in Populations of African Descent

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
83
Enrollment target

NCT03937804 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 83 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03937804 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
83 participants
Enrollment target

Study Summary

Background: Some groups of people have a high prevalence of asthma and allergic disease. Also, asthma and allergic disease are often found in several members of the same family. Researchers want to learn more about what factors might cause asthma, both genetic and environmental. Objective: To build a collection of information to try to find genes that cause conditions and disorders such as asthma and allergic disease. Eligibility: People ages 18 99 of self-identified African, African American, or African Caribbean descent who either have no history of asthma or wheeze or have a physician s diagnosis of asthma Design: Participants will be screened with an interview by phone or in person. Participants will fill out a questionnaire about their general health and exposure to allergens and smoke. Participants will have a physical exam. Participants will have blood tests. Participants will provide a skin cell sample. Up to two samples will be taken from the inside of the nose. A brush will be used to take the samples. Participants will have a breathing test. They will be asked to blow forcefully 3 or more times into a lung function machine. Participants may have their blood and skin samples sent to a lab. DNA will be extracted from the samples and tested. Participants blood and skin samples will be stored. Samples may be used in future research studies.

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2019-09-23
Est. Completion 2021-11-15

What the Registry Record Tells You About NCT03937804

The ClinicalTrials.gov registry entry for NCT03937804 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03937804 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03937804 about?

NCT03937804 is a clinical study titled "New Approaches for Empowering Studies of Asthma in Populations of African Descent". Background: Some groups of people have a high prevalence of asthma and allergic disease. Also, asthma and allergic disease are often found in several members of the same family. Researchers want to learn more about what factors might cause asthma, both genetic and environmental. Objective: To bui...

What is the current status of trial NCT03937804?

This trial is currently completed. The enrollment target is 83 participants. The study started on 2019-09-23. Estimated completion is 2021-11-15.

Who is sponsoring clinical trial NCT03937804?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.